India - English - Central Drugs Standard Control Organization

natco ph. - ciprofloxacin - tablets - cipronat® is indicated in the treatment of following infections caused by susceptible strains of bacteria: acute sinusitis: due to haemophilus influenzae, streptococcus pneumoniae, moraxella catarrhalis. lower respiratory tract infections: pneumonia, cystic fibrosis and acute exacerbations of chronic bronchitis, due to e.coli, klebsiella pneumoniae, enterobacter cloacae, proteus mirabilis, pseudomonas aeruginosa, haemophilus influenzae and parainfluenzae, streptococcus pneumoniae, moraxella catarrhalis (bronchitis). urinary tract infections: due to e. coli, klebsiella pneumoniae. enterobacter cloacae, serratia marcescens, proteus mirabilis, proteus rettgeri, morganella morganii, citrobacter diversus and freundii, pseudomonas aeruginosa, staphylococcus epidermidis and saprophyticus, enterococcus faecalis.

Philippines - English - FDA (Food And Drug Administration)

sandoz philippines corporation - ondansetron (as hydrochloride) - tablet, film coated - 8mg

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

الجديد للصناعات الدوائية - al-gadeed pharmaceutiacl industries - ondansetron (hydrochloride dihydrate) 4 mg/5 ml - 4 mg/5 ml

Uganda - English - National Drug Authority

dafra pharma ltd - beta artemether + lumefantrine - oral liquid ordinary dry suspensions/syrups/drops - 180 mg/60ml + 1080 mg/60ml

Uganda - English - National Drug Authority

dafra pharma ltd - artemether - parenteral ordinary i m ampoules - 80mg/ml

Uganda - English - National Drug Authority

dafra pharma ltd - artemether - parenteral ordinary i m ampoules - 20mg/ml

Uganda - English - National Drug Authority

dafra pharma n.v/s.a - meropenem - parenteral ordinary vials - 1000mg

Uganda - English - National Drug Authority

dafra pharma n.v/s.a - meropenem - parenteral ordinary dry vials - 500mg